Classes
Publications
- Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection2013 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells2013 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury2010 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo +12008 | Faculty of Medicine in Hradec Králové
- Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone +12008 | Faculty of Medicine in Hradec Králové
- Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: A study of salicylaldehyde isonicotinoyl hydrazone (SIH) +12007 | Faculty of Medicine in Hradec Králové
- New iron chelators in anthracycline-induced cardiotoxicity +12007 | Faculty of Medicine in Hradec Králové
- Anthracycline cardiotoxicity and the possibility of the pharmacological cardioprotection2007 | Faculty of Medicine in Hradec Králové
- HPLC determination of a novel aroylhydrazone iron chelator (o-108) in rabbit plasma and its application to a pilot pharmacokinetic study2006 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Cardioprotective effects of a novel iron chelator, pyridoxal 2-chlorobenzoyl hydrazone, in the rabbit model of daunorubicin-induced cardiotoxicity +12006 | Faculty of Medicine in Hradec Králové
Loading network view...